Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
12 – 75
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
603 (estimated)
Sponsor
Beijing InnoCare Pharma Tech Co., Ltd. · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This a phase II/III randomized, double-blind, placebo-controlled, parallel group, adaptive design, multi-center study to evaluate the efficacy and safety of ICP-332 in subjects with non-segmental vitiligo。The study consisted an phase 2 part and an phase 3 part.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
1. Male or female subjects aged ≥18 years and ≤75 years (Phase II portion). Male or female subjects ≥12 years of age and ≤75 years of age, adolescent subjects must weigh ≥40 kg (Phase III portion).
2. Eligible subjects must meet all of the following criteria at screening and bas…
Inclusion Criteria:
1. Male or female subjects aged ≥18 years and ≤75 years (Phase II portion). Male or female subjects ≥12 years of age and ≤75 years of age, adolescent subjects must weigh ≥40 kg (Phase III portion).
2. Eligible subjects must meet all of the following criteria at screening and baseline:
1. The clinical diagnosis was non-segmental vitiligo for at least 3 months.
2. Involvement of BSA≥5%.
3. Facial involvement BSA≥0.5%.
4. F-VASI≥0.5 and T-VASI between 5 and 50.
5. Active or stable non-segmental vitiligo was present at both screening and baseline visits.
3. Women of childbearing potential (WOCBP) and Men must agree to contraception.
4. Before beginning any screening or study specific procedures, subjects must voluntarily sign informed consent.
Exclusion Criteria:
1. Any of the following vitiligo related medical conditions and other skin diseases/conditions.
a) Subjects had other types of vitiligo (including but not limited to segmental vitiligo and mixed vitiligo) that did not meet the criteria for active or stable vitiligo described in Inclusion criteria 2.
2. History of any clinically major diseases, with the exception of vitiligo.
3. Pregnant or breastfeeding females.
4. The investigator considers that the subject is not suitable for participation in this study for any reason.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.